| Pathfinder Cell Therapy, Inc. Announces New Stock Ticker Symbol - PR Newswire (press release) |
|
|
PR Newswire (press release) Pathfinder is developing a novel cell-based therapy with the potential to transform the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. Leveraging its internal discovery of |